| Product Code: ETC13189640 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Pleurisy Disease Market was valued at USD 0.16 Billion in 2024 and is expected to reach USD 0.22 Billion by 2031, growing at a compound annual growth rate of 5.40% during the forecast period (2025-2031).
The global pleurisy disease market is expected to witness steady growth due to an increasing prevalence of respiratory conditions such as pneumonia, tuberculosis, and lung cancer. Pleurisy, characterized by inflammation of the pleura surrounding the lungs, is often a complication of these underlying respiratory illnesses. The market is driven by advancements in diagnostic technologies such as imaging tests and laboratory assessments, leading to early and accurate diagnosis of pleurisy. Moreover, the rising awareness about respiratory health and the availability of effective treatment options like antibiotics, anti-inflammatory drugs, and surgical interventions are bolstering market growth. Key players in the global pleurisy disease market include pharmaceutical companies, diagnostic laboratories, and healthcare providers, working towards developing innovative therapies and improving patient outcomes. The market is expected to continue expanding as healthcare infrastructure improves, particularly in emerging economies.
The global pleurisy disease market is experiencing growth driven by factors such as the increasing prevalence of respiratory conditions, advancements in diagnostic techniques, and a growing awareness about the disease among healthcare professionals and patients. Opportunities in the market include the development of novel treatment options, expansion of healthcare infrastructure in emerging markets, and collaborations between pharmaceutical companies and research institutions to drive innovation. The market is also witnessing a shift towards personalized medicine and targeted therapies, as well as a growing focus on improving patient outcomes and quality of life. Companies operating in this market have the opportunity to diversify their product portfolios, expand their market presence globally, and leverage technological advancements to address the unmet needs of patients with pleurisy disease.
The Global Pleurisy Disease Market faces several challenges, including limited awareness among healthcare professionals and patients leading to underdiagnosis, as well as the lack of specific diagnostic tools for accurate and timely detection. Additionally, the variability in symptoms and underlying causes of pleurisy can make it difficult to develop targeted treatment options, resulting in a one-size-fits-all approach that may not be effective for all patients. Furthermore, the high cost of treatment and limited reimbursement options for pleurisy management pose financial barriers for patients seeking care. Overall, addressing these challenges requires increased education and awareness efforts, as well as research and development initiatives to improve diagnostic capabilities and personalized treatment strategies in the Global Pleurisy Disease Market.
The global pleurisy disease market is primarily driven by factors such as the increasing prevalence of pleurisy worldwide, growing awareness about the condition and its symptoms leading to early diagnosis and treatment, advancements in diagnostic techniques for pleurisy, and the rising adoption of minimally invasive procedures for the treatment of pleural effusions. Additionally, the aging population, higher incidence of respiratory diseases, and the development of novel therapeutics targeting pleurisy are also contributing to the market growth. Government initiatives to improve healthcare infrastructure and the availability of reimbursement policies for pleurisy treatments further fuel market expansion. Overall, the market is expected to continue growing as the demand for effective pleurisy management options increases globally.
Government policies related to the Global Pleurisy Disease Market focus on improving diagnosis and treatment options, reducing healthcare costs, and promoting research and development for innovative therapies. Policies may include funding for research initiatives, regulatory approvals for new treatments, and guidelines for healthcare providers to follow in managing pleurisy cases. Governments also aim to increase access to affordable healthcare services for patients with pleurisy, ensuring timely diagnosis and appropriate treatment. Additionally, policies may address issues such as insurance coverage for pleurisy-related treatments and interventions to prevent the spread of the disease. Overall, government policies in the Global Pleurisy Disease Market are aimed at enhancing patient outcomes, advancing medical knowledge, and fostering a supportive environment for healthcare innovation.
The Global Pleurisy Disease Market is expected to witness steady growth in the coming years, driven by factors such as the rising prevalence of respiratory diseases, advancements in diagnostic techniques, and increasing healthcare expenditure worldwide. The market is likely to benefit from a growing awareness about pleurisy among healthcare professionals and patients, leading to early diagnosis and treatment. Additionally, the introduction of novel treatment options and therapies is anticipated to further boost market growth. However, challenges such as limited access to healthcare in developing regions and high treatment costs could potentially hinder market expansion. Overall, with ongoing research and development activities in the field of respiratory medicine, the Global Pleurisy Disease Market is poised for gradual but sustained growth in the foreseeable future.
In the Global Pleurisy Disease Market, regional insights reveal varying trends across different regions. In Asia, the market is witnessing significant growth due to the rising prevalence of respiratory diseases and improving healthcare infrastructure. North America boasts a mature market with well-established healthcare systems and high adoption of advanced treatments, leading to a strong presence of key market players. Europe is experiencing steady growth driven by increasing healthcare expenditure and a growing geriatric population. The Middle East and Africa region is showing potential for growth, supported by initiatives to enhance healthcare access and infrastructure development. Latin America is also emerging as a promising market with improving healthcare facilities and a growing awareness of respiratory diseases among the population.
Global Pleurisy Disease Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Pleurisy Disease Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Pleurisy Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Global Pleurisy Disease Market - Industry Life Cycle |
3.4 Global Pleurisy Disease Market - Porter's Five Forces |
3.5 Global Pleurisy Disease Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Pleurisy Disease Market Revenues & Volume Share, By Diagnostic Type, 2021 & 2031F |
3.7 Global Pleurisy Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Global Pleurisy Disease Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.9 Global Pleurisy Disease Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Global Pleurisy Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Pleurisy Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Pleurisy Disease Market Trends |
6 Global Pleurisy Disease Market, 2021 - 2031 |
6.1 Global Pleurisy Disease Market, Revenues & Volume, By Diagnostic Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Pleurisy Disease Market, Revenues & Volume, By Thoracentesis, 2021 - 2031 |
6.1.3 Global Pleurisy Disease Market, Revenues & Volume, By Video-Assisted Thoracic Surgery, 2021 - 2031 |
6.1.4 Global Pleurisy Disease Market, Revenues & Volume, By Imaging Devices, Blood Test, 2021 - 2031 |
6.1.5 Global Pleurisy Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Pleurisy Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Pleurisy Disease Market, Revenues & Volume, By Antibiotics, 2021 - 2031 |
6.2.3 Global Pleurisy Disease Market, Revenues & Volume, By Antifungals, 2021 - 2031 |
6.2.4 Global Pleurisy Disease Market, Revenues & Volume, By Blood Thinners, 2021 - 2031 |
6.2.5 Global Pleurisy Disease Market, Revenues & Volume, By Nonsteroidal Anti-Inflammatory Drugs, 2021 - 2031 |
6.2.6 Global Pleurisy Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Pleurisy Disease Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Pleurisy Disease Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.3.3 Global Pleurisy Disease Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.4 Global Pleurisy Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Pleurisy Disease Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.4.3 Global Pleurisy Disease Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 Global Pleurisy Disease Market, Revenues & Volume, By Diagnostics Laboratories, 2021 - 2031 |
6.4.5 Global Pleurisy Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Pleurisy Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Pleurisy Disease Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.5.3 Global Pleurisy Disease Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.5.4 Global Pleurisy Disease Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
6.5.5 Global Pleurisy Disease Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Pleurisy Disease Market, Overview & Analysis |
7.1 North America Pleurisy Disease Market Revenues & Volume, 2021 - 2031 |
7.2 North America Pleurisy Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Pleurisy Disease Market, Revenues & Volume, By Diagnostic Type, 2021 - 2031 |
7.4 North America Pleurisy Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.5 North America Pleurisy Disease Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
7.6 North America Pleurisy Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7 North America Pleurisy Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Pleurisy Disease Market, Overview & Analysis |
8.1 Latin America (LATAM) Pleurisy Disease Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Pleurisy Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Pleurisy Disease Market, Revenues & Volume, By Diagnostic Type, 2021 - 2031 |
8.4 Latin America (LATAM) Pleurisy Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.5 Latin America (LATAM) Pleurisy Disease Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
8.6 Latin America (LATAM) Pleurisy Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
8.7 Latin America (LATAM) Pleurisy Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Pleurisy Disease Market, Overview & Analysis |
9.1 Asia Pleurisy Disease Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Pleurisy Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Pleurisy Disease Market, Revenues & Volume, By Diagnostic Type, 2021 - 2031 |
9.4 Asia Pleurisy Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.5 Asia Pleurisy Disease Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
9.6 Asia Pleurisy Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
9.7 Asia Pleurisy Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Pleurisy Disease Market, Overview & Analysis |
10.1 Africa Pleurisy Disease Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Pleurisy Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Pleurisy Disease Market, Revenues & Volume, By Diagnostic Type, 2021 - 2031 |
10.4 Africa Pleurisy Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.5 Africa Pleurisy Disease Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
10.6 Africa Pleurisy Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
10.7 Africa Pleurisy Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Pleurisy Disease Market, Overview & Analysis |
11.1 Europe Pleurisy Disease Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Pleurisy Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Pleurisy Disease Market, Revenues & Volume, By Diagnostic Type, 2021 - 2031 |
11.4 Europe Pleurisy Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.5 Europe Pleurisy Disease Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
11.6 Europe Pleurisy Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
11.7 Europe Pleurisy Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Pleurisy Disease Market, Overview & Analysis |
12.1 Middle East Pleurisy Disease Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Pleurisy Disease Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Pleurisy Disease Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Pleurisy Disease Market, Revenues & Volume, By Diagnostic Type, 2021 - 2031 |
12.4 Middle East Pleurisy Disease Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.5 Middle East Pleurisy Disease Market, Revenues & Volume, By Route Of Administration, 2021 - 2031 |
12.6 Middle East Pleurisy Disease Market, Revenues & Volume, By End User, 2021 - 2031 |
12.7 Middle East Pleurisy Disease Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Pleurisy Disease Market Key Performance Indicators |
14 Global Pleurisy Disease Market - Export/Import By Countries Assessment |
15 Global Pleurisy Disease Market - Opportunity Assessment |
15.1 Global Pleurisy Disease Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Pleurisy Disease Market Opportunity Assessment, By Diagnostic Type, 2021 & 2031F |
15.3 Global Pleurisy Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.4 Global Pleurisy Disease Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
15.5 Global Pleurisy Disease Market Opportunity Assessment, By End User, 2021 & 2031F |
15.6 Global Pleurisy Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Pleurisy Disease Market - Competitive Landscape |
16.1 Global Pleurisy Disease Market Revenue Share, By Companies, 2024 |
16.2 Global Pleurisy Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |